
GLP-2 TZ
- Bundle strength
- 30 mg
- Certificate sample
- 10 mg
- Reported purity
- 99.95%
- Lot
- FTMXBK
Reference certificate only. It does not represent the 30 mg bundle unit.

A three-compound set for laboratory research involving GLP-2 receptor signalling, NNMT and NAD+ salvage, and growth-hormone releasing hormone pathways.



You save $18.00. The 10% bundle price is shown again in your cart and checkout.
For laboratory research use only. Not for human or veterinary use.
Plateau Breaker is a fixed set of three separate research vials: GLP-2 TZ 30 mg, 5-Amino-1MQ 50 mg, and Tesamorelin 10 mg. Each compound keeps its own identity, labeled strength, and certificate record. The set is sold as one catalog item. Components cannot be removed or swapped in this version. It is not a combined mechanism and it is not a subscription.
GLP-2 TZ 30 mg · 5-Amino-1MQ 50 mg · Tesamorelin 10 mg
Open the certificate associated with each component. Certificates report the specific sample and lot tested; the certificate strength is shown plainly below.

Reference certificate only. It does not represent the 30 mg bundle unit.


Certificate scope: Results apply only to the sample and lot identified in each document. A lot-specific certificate should be checked against the vial received before research begins.
Each vial is cataloged on its own research pathway. The diagram names the three components. It does not describe a combined mechanism.
A 33 amino acid analog of glucagon-like peptide-2, the teduglutide-type sequence. A substitution at the second position resists DPP-4. Studies have measured intestinal villus height, crypt depth, and mucosal barrier function in resection and injury models.
A small molecule rather than a peptide. It blocks nicotinamide N-methyltransferase, which consumes nicotinamide used in NAD+ synthesis. Studies have measured NAD+ levels when that enzyme is blocked.
A synthetic version of growth hormone releasing hormone. The sequence matches the full 44 amino acid human hormone, with a trans-3-hexenoic acid group that resists DPP-4. Research has measured growth hormone output in study models.
The set covers three catalog research areas. A shared shipment does not make the compounds interchangeable.
Villus height, crypt depth, and mucosal barrier function are the recorded endpoints in resection and injury models. The research material on this page is not the licensed GLP-2 medicine.
NNMT blockade and the resulting change in nicotinamide available for NAD+ synthesis are the recorded research areas for this small molecule.
Pituitary GHRH-receptor signalling and measured growth hormone output are the recorded research areas. This vial is not the approved pharmaceutical formulation.
This set is not one molecule. Each vial keeps the identity published on its own catalog record. A figure that record does not print is left off this page.
GLP-2 TZ · 30 mg
5-Amino-1MQ · 50 mg
Tesamorelin · 10 mg
| Set | GLP-2 TZ, 5-Amino-1MQ, Tesamorelin — three separate vials |
| GLP-2 TZ | 30 mg · 1 vial · 3752 g/mol · 33 residues |
| 5-Amino-1MQ | 50 mg · 1 vial · C10H10N2 · CAS 4213-45-0 |
| Tesamorelin | 10 mg · 1 vial · C221H366N72O67S · CAS 218949-48-5 |
| Form | Lyophilized material |
| Purchase | Fixed set. One-time purchase only. Components cannot be removed. |
| Price | $161.97 · 10% off $179.97 |
| Testing | Third-party HPLC on each published certificate |
| GLP-2 TZ certificate | 10 mg reference · 99.95% · lot FTMXBK |
| 5-Amino-1MQ certificate | 50 mg · 99.77% · lot D778RG |
| Tesamorelin certificate | 10 mg · 99.93% · lot AV2C30 |
| Storage | -20°C, protected from light and moisture |
| Use | In-vitro laboratory research only |
No. This version is a fixed three-product set. Components cannot be removed.
No. Plateau Breaker is a one-time purchase only. There is no recurring billing option on this page.
The published GLP-2 TZ certificate was produced from a 10 mg sample. This set contains a 30 mg vial, so that document is shown for transparency and is not presented as a lot-matched certificate for the bundle unit. The 5-Amino-1MQ and Tesamorelin certificates match the 50 mg and 10 mg units in the set.
Match the lot identifier on each vial against its accompanying certificate or the COA Library. Contact support if a lot-specific document is not available.
Store each lyophilized vial at -20°C, protected from light and moisture. Follow the storage note on the individual product record if it is more specific.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.